Alnylam pharmaceuticals inc

Major-Pharmaceuticals

ALNY


300 Third Street
Cambridge , MA 02142

Executive/
Director

Price

  • Last Close
  • $ 234.4
    $ +0.79 0.34 %
    Jan 3, 2025
  • 52-Week High/Low
  • $287.01 - $144.35
  • YTD
  • 0%

  • Trading Volume
  • 13,201
  • Market Cap Full
  • $ 29.4B
  • Shares Outstanding
  • 125.5M
    Oct 27, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 36.9% -6.3% 28.2% -5% 8.6% -6.4% -15.7% -22% -0.4% -
Q2 55.6% -2.7% -21.4% 4% 20.1% -10.7% -5.2% 61.1% - -
Q3 47.3% -10.8% 10% 8% 9% 37.2% -6.8% 20.9% - -
Q4 3.9% -17.5% 48.1% -10.7% -5.6% 18.7% 7% -15.9% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 -0.4% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -60%239%-43%59%12%34%36%-19%23%-0%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 1.25 -1.41 -1.73 -1.62 -1.71 -2 -1.40
Q2 1.34 -1.63 -2.02 -1.56 -1.61 -2.29 -2.21
Q3 1.34 -2.43 -1.92 -2.18 -1.72 -3.32 1.15
Q4 1.48 -2.1 -2.44 -2.1 -2.16 -1.69 -
A 5.4 -7.6 -8.1 -7.5 -7.2 -9.3 -2.46

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 106.3 112.6 117 120.2 124.1
Jun 100.5 106.5 114.8 117.5 120.8 124.5
Sep 100.7 111.2 116 118.8 120 125
Dec 101 111.5 116.2 119.6 123 125.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.3 1.6 1 0.5 0.1
Fixed Asset Turnover 1.6 1.4 0.9 0.5 0.2
Total Asset Turnover 0.3 0.2 0.1 0.1 0.1
Leverage
Debt Ratio - 0.2 0.1 - -
Debt – Equity Ratio - 1.2 0.2 - -
Interest Coverage -2.3 -4.9 -27.6 17.7 15.4
Equity multiplier -4 1 0.5 0.3 0.3